Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004911 220001931 1.59 null Curative (C) 2016-10-19 2016-10-19 LI-1 TRIAL 01 N 220027049 TRIAL
220004912 220001932 1.7 77.8 Adjuvant (A) 2016-02-15 2016-02-15 AML17 TRIAL Y N 220027056 AML17 TRIAL
220004913 220001932 1.77 64.4 Curative (C) 2013-04-02 2013-04-02 Trial Unspecified 01 N 220027056 TRIAL
220004914 220001932 1.7 91.5 null 2016-10-06 2016-10-06 AML17 TRIAL 01 null 220027056 AML17 TRIAL
220004915 220001933 null 63.1 null 2014-01-05 2014-01-05 AML17 TRIAL 1 N 220027062 AML17 TRIAL
220004916 220001933 1.8 84.4 Curative (C) 2016-11-09 2016-11-13 AML17 TRIAL N N 220027062 AML17 TRIAL
220004917 220001933 1.68 null Palliative (P) 2015-06-12 2015-06-19 CYTARABINE N N 220027062 CYTARABINE
220004918 220001934 1.57 null Curative (C) 2016-11-20 2016-12-03 CYTARABINE 02 null 220027066 CYTARABINE
220004919 220011005 1.9 79.25 Not known (9) 2013-03-28 2013-03-30 Trial Unspecified 01 null 220027070 TRIAL
220004920 220011005 null 105 null 2016-02-03 2016-02-03 Cytarabine low (10to20mg/m2) IV/SC 02 N 220027070 CYTARABINE
220004921 220001935 null 59.2 null 2017-08-18 2017-08-18 Trial Unspecified 01 N 220027072 TRIAL
220004922 220001935 1.73 null Curative (C) null 2014-02-10 AML17 TRIAL null null 220027072 AML17 TRIAL
220004923 220001935 1.73 90.8 Radical (R) 2017-01-12 2017-01-12 Cytarabine Low Dose 02 N 220027072 CYTARABINE
220004924 220001935 1.74 null Curative (C) 2013-06-22 2013-06-22 CYTARABINE N null 220027072 CYTARABINE
220004925 220001936 1.78 81.5 Palliative (P) 2014-01-08 2014-01-22 Cytarabine low (10to20mg/m2) IV/SC null N 220027078 CYTARABINE
220004926 220001936 1.6 80 Palliative (P) 2016-12-08 2016-12-08 Trial Unspecified 1 null 220027078 TRIAL
220004927 220001936 1.74 70.3 Palliative (P) 2013-07-11 2013-07-11 CYTARABINE N N 220027078 CYTARABINE
220004928 220001937 1.9 71 Palliative (P) 2015-09-25 2015-09-25 Cytarabine Low Dose N N 220027084 CYTARABINE
220004929 220001937 1.79 null null 2016-10-18 2016-10-18 Trial Unspecified null null 220027084 TRIAL
220004930 220001937 1.53 70.5 Curative (C) 2014-03-05 2014-03-05 AML17 TRIAL 1 N 220027084 AML17 TRIAL
220004931 220001937 1.68 116 Curative (C) 2013-06-20 2013-06-20 AML17 TRIAL 01 N 220027084 AML17 TRIAL
220004932 220001937 1.6 null Disease modification (D) 2017-06-08 2017-06-22 Cytarabine low (10to20mg/m2) IV/SC N N 220027084 CYTARABINE
220004933 220001938 1.73 59.8 Disease modification (D) 2016-08-25 2016-08-25 Trial Unspecified Y N 220027097 TRIAL
220004934 220001938 1.79 58 null 2017-03-11 2017-03-11 Cytarabine low (10to20mg/m2) IV/SC 02 N 220027097 CYTARABINE
220004935 220015883 1.82 0 Disease modification (D) 2015-09-15 2015-09-15 Cytarabine Low Dose N N 220027103 CYTARABINE
220004936 220001939 1.81 66.2 Curative (C) 2017-07-29 2017-07-29 AML17 TRIAL 01 null 220027108 AML17 TRIAL
220004937 220001939 1.67 null Curative (C) 2015-02-17 2015-04-02 Trial Unspecified Y N 220027108 TRIAL
220004938 220015884 1.63 62 Palliative (P) 2017-07-06 2017-07-06 Cytarabine low (10to20mg/m2) IV/SC 02 N 220027110 CYTARABINE
220004939 220015884 1.72 null Curative (C) 2016-07-13 2016-07-15 Cytarabine Low Dose null null 220027110 CYTARABINE
220004940 220015884 1.66 91.1 Curative (C) 2015-06-08 2015-06-08 Trial Unspecified N N 220027110 TRIAL
220004941 220001940 1.58 74 Curative (C) 2016-09-07 2016-09-20 Trial Unspecified N N 220027115 TRIAL
220004942 220001941 null 62.4 Curative (C) 2015-03-04 2015-03-17 AML17 TRIAL null N 220027120 AML17 TRIAL
220004943 220001941 1.58 null Disease modification (D) 2014-06-16 2014-06-16 Cytarabine low (10to20mg/m2) IV/SC 02 null 220027120 CYTARABINE
220004944 220001941 1.78 null Curative (C) 2016-12-18 2016-12-18 AML17 TRIAL N N 220027120 AML17 TRIAL
220004945 220001942 1.77 58.4 Curative (C) null 2013-01-17 AML17 TRIAL null null 220027132 AML17 TRIAL
220004946 220001943 1.84 68 Curative (C) null 2018-01-14 Trial Unspecified Y null 220027135 TRIAL
220004947 220001943 1.62 70 Curative (C) 2016-11-01 2016-11-02 AML17 TRIAL Y N 220027135 AML17 TRIAL
220004948 220001943 null 66 Curative (C) 2016-07-11 2016-07-11 Trial Unspecified 01 N 220027135 TRIAL
220004949 220001943 1.91 78.7 Curative (C) 2015-04-07 2015-04-07 Trial Unspecified Y null 220027135 TRIAL
220004950 220001943 1.67 null Palliative (P) 2013-05-29 2013-05-29 Cytarabine low (10to20mg/m2) IV/SC N N 220027135 CYTARABINE
220004951 220001943 1.88 73.7 Curative (C) 2016-02-14 2016-02-15 LI-1 TRIAL 1 N 220027135 TRIAL
220004952 220001944 null null null 2013-10-10 2013-10-10 LI-1 TRIAL Y N 220027147 TRIAL
220004953 220001944 1.75 null Adjuvant (A) 2015-02-12 2015-02-14 Cytarabine Low Dose 2 N 220027147 CYTARABINE
220004955 220001945 1.52 0 Curative (C) 2017-06-08 2017-06-08 Trial Unspecified 1 N 220027157 TRIAL
220004958 220001947 null 0 null 2017-07-27 2017-07-27 Trial Unspecified Y N 220027160 TRIAL
220004959 220001948 1.76 74.5 null null 2017-05-08 LI-1 TRIAL Y null 220027162 TRIAL
220004960 220001948 1.62 null Palliative (P) 2015-03-15 2015-03-15 Cytarabine Low Dose 02 N 220027162 CYTARABINE
220004961 220001949 1.5 115.4 Curative (C) 2017-04-08 2017-04-08 LI-1 TRIAL 1 N 220027167 TRIAL
220004962 220001949 null 97.6 Curative (C) 2015-03-27 2015-04-13 LI-1 TRIAL Y N 220027167 TRIAL
220004963 220001950 1.58 104 Palliative (P) 2016-09-11 2016-09-11 Cytarabine Low Dose 2 N 220027169 CYTARABINE